Last 12 months
Inside the activity.
1 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 1 | 7 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 6, 2026 20:05 UTC |
Dube Michael PVP, Chief Accounting Officer
|
SaleCommon Stock | 1,864 | $12.43 | $23,169.52 |
DisclosureSEC source: 0001193125-26-415541 · ownership.xml · nonDerivative · entry 1 Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,022 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2026, and does not represent a volitional trade by the Reporting Person. Read SEC document |
| August 21, 2026 Filed Aug 24, 2026 20:05 UTC |
LEONARD JOHN MDirector · President and CEO
|
SaleCommon Stock | 2,785 | $13.00 | $36,205.00 |
DisclosureSEC source: 0001193125-26-363567 · ownership.xml · nonDerivative · entry 2 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,147,064 F1 · kind: The sales reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 20:05 UTC |
LEONARD JOHN MDirector · President and CEO
|
SaleCommon Stock | 19,890 | $12.60 | $250,614.00 |
DisclosureSEC source: 0001193125-26-363567 · ownership.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,149,849 F1 · kind: The sales reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.32 to $13.00, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 20, 2026 at each separate price. Read SEC document |
| July 22, 2026 Filed Jul 24, 2026 21:26 UTC |
Dulac Edward J IIIEVP, Chief Financial Officer
|
SaleCommon Stock | 8,111 | $11.25 | $91,248.75 |
DisclosureSEC source: 0001193125-26-316279 · ownership.xml · nonDerivative · entry 1 Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,175 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 22, 2026, and does not represent a volitional trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.25 to $11.28, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 22, 2026 at each separate price. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 21:01 UTC |
Dulac Edward J IIIEVP, Chief Financial Officer
|
SaleCommon Stock | 4,677 | $18.00 | $84,186.00 |
DisclosureSEC source: 0001821530-26-000002 · ownership.xml · nonDerivative · entry 1 Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,286 F1 · kind: The reported sale of 4,677 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 8, 2025. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:02 UTC |
Dube Michael PVP, Chief Accounting Officer
|
SaleCommon Stock | 2,641 | $16.78 | $44,315.98 |
DisclosureSEC source: 0002019493-26-000002 · ownership.xml · nonDerivative · entry 1 Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,886 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2026, and does not represent a volitional trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.78 to $17.12, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2026 at each separate price. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:06 UTC |
GOODMAN JESSEDirector
|
GrantStock Option (right to buy) · Derivative | 13,300 | $0.00 Strike: $12.89 | $0.00 |
DisclosureSEC source: 0001756929-26-000002 · ownership.xml · derivative · entry 2 GOODMAN JESSE · CIK 0001756929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2036-06-08 F2 · derivative.exercise_date: This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:06 UTC |
GOODMAN JESSEDirector
|
GrantCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001756929-26-000002 · ownership.xml · nonDerivative · entry 1 GOODMAN JESSE · CIK 0001756929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,559 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:08 UTC |
Verwiel FrankDirector
|
GrantStock Option (right to buy) · Derivative | 13,300 | $0.00 Strike: $12.89 | $0.00 |
DisclosureSEC source: 0001545794-26-000001 · ownership.xml · derivative · entry 2 Verwiel Frank · CIK 0001545794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2036-06-08 F2 · derivative.exercise_date: This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:08 UTC |
Verwiel FrankDirector
|
GrantCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001545794-26-000001 · ownership.xml · nonDerivative · entry 1 Verwiel Frank · CIK 0001545794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,148 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:02 UTC |
Goff BrianDirector
|
GrantStock Option (right to buy) · Derivative | 13,300 | $0.00 Strike: $12.89 | $0.00 |
DisclosureSEC source: 0001193125-26-266236 · ownership.xml · derivative · entry 2 Goff Brian · CIK 0001546216 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2036-06-08 F2 · derivative.exercise_date: This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:02 UTC |
Goff BrianDirector
|
GrantCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-266236 · ownership.xml · nonDerivative · entry 1 Goff Brian · CIK 0001546216 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,609 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:07 UTC |
Keresty GeorgiaDirector
|
GrantStock Option (right to buy) · Derivative | 13,300 | $0.00 Strike: $12.89 | $0.00 |
DisclosureSEC source: 0001193125-26-266241 · ownership.xml · derivative · entry 2 Keresty Georgia · CIK 0001773532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2036-06-08 F2 · derivative.exercise_date: This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:07 UTC |
Keresty GeorgiaDirector
|
GrantCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-266241 · ownership.xml · nonDerivative · entry 1 Keresty Georgia · CIK 0001773532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,083 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:00 UTC |
CHASE WILLIAM JDirector
|
GrantStock Option (right to buy) · Derivative | 13,300 | $0.00 Strike: $12.89 | $0.00 |
DisclosureSEC source: 0001563572-26-000001 · ownership.xml · derivative · entry 2 CHASE WILLIAM J · CIK 0001563572 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2036-06-08 F2 · derivative.exercise_date: This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:00 UTC |
CHASE WILLIAM JDirector
|
GrantCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001563572-26-000001 · ownership.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,893 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:01 UTC |
Cohen Fred EDirector
|
GrantStock Option (right to buy) · Derivative | 13,300 | $0.00 Strike: $12.89 | $0.00 |
DisclosureSEC source: 0001193125-26-266233 · ownership.xml · derivative · entry 2 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2036-06-08 F2 · derivative.exercise_date: This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:01 UTC |
Cohen Fred EDirector
|
GrantCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-266233 · ownership.xml · nonDerivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,653 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 22:57 UTC |
Bhanji MunaDirector
|
GrantStock Option (right to buy) · Derivative | 13,300 | $0.00 Strike: $12.89 | $0.00 |
DisclosureSEC source: 0001193125-26-266230 · ownership.xml · derivative · entry 2 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2036-06-08 F2 · derivative.exercise_date: This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 22:57 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-266230 · ownership.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,403 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:18 UTC |
BASTA JAMESEVP, General Counsel
|
SaleCommon Stock | 1,211 | $13.78 | $16,687.58 |
DisclosureSEC source: 0001193125-26-088260 · ownership.xml · nonDerivative · entry 2 BASTA JAMES · CIK 0001792726 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,794 F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:16 UTC |
Clark ElianaEVP, Chief Technical Officer
|
SaleCommon Stock | 607 | $13.78 | $8,364.46 |
DisclosureSEC source: 0001193125-26-088241 · ownership.xml · nonDerivative · entry 2 Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,864 F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:17 UTC |
Schultes Birgit CEVP, Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 56,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0001193125-26-088251 · ownership.xml · derivative · entry 2 Schultes Birgit C · CIK 0002051419 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,000 Underlying: Common Stock · 56,000 shares Expires 2036-02-29 F2 · derivative.exercise_date: This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:17 UTC |
Schultes Birgit CEVP, Chief Scientific Officer
|
GrantCommon Stock | 39,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088251 · ownership.xml · nonDerivative · entry 1 Schultes Birgit C · CIK 0002051419 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,733 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:15 UTC |
Dube Michael PVP, Chief Accounting Officer
|
GrantCommon Stock | 17,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088236 · ownership.xml · nonDerivative · entry 1 Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,527 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:18 UTC |
Lebwohl DavidEVP, Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 14,204 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0001193125-26-088258 · ownership.xml · derivative · entry 2 Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,204 Underlying: Common Stock · 14,204 shares Expires 2036-02-29 F2 · derivative.exercise_date: This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:18 UTC |
Lebwohl DavidEVP, Chief Medical Officer
|
GrantCommon Stock | 9,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088258 · ownership.xml · nonDerivative · entry 1 Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,192 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:19 UTC |
LEONARD JOHN MDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 225,400 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0001193125-26-088269 · ownership.xml · derivative · entry 3 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,400 Underlying: Common Stock · 225,400 shares Expires 2036-02-29 F3 · derivative.exercise_date: This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:19 UTC |
LEONARD JOHN MDirector · President and CEO
|
GrantCommon Stock | 156,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088269 · ownership.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,169,739 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:18 UTC |
BASTA JAMESEVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 65,829 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0001193125-26-088260 · ownership.xml · derivative · entry 3 BASTA JAMES · CIK 0001792726 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,829 Underlying: Common Stock · 65,829 shares Expires 2036-02-29 F3 · derivative.exercise_date: This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:18 UTC |
BASTA JAMESEVP, General Counsel
|
GrantCommon Stock | 46,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088260 · ownership.xml · nonDerivative · entry 1 BASTA JAMES · CIK 0001792726 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,005 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:16 UTC |
Clark ElianaEVP, Chief Technical Officer
|
GrantStock Option (right to buy) · Derivative | 10,505 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0001193125-26-088241 · ownership.xml · derivative · entry 3 Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,505 Underlying: Common Stock · 10,505 shares Expires 2036-02-29 F3 · derivative.exercise_date: This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:16 UTC |
Clark ElianaEVP, Chief Technical Officer
|
GrantCommon Stock | 7,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088241 · ownership.xml · nonDerivative · entry 1 Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,471 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:17 UTC |
Dulac Edward J IIIEVP, Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 87,543 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0001193125-26-088254 · ownership.xml · derivative · entry 2 Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,543 Underlying: Common Stock · 87,543 shares Expires 2036-02-29 F2 · derivative.exercise_date: This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:17 UTC |
Dulac Edward J IIIEVP, Chief Financial Officer
|
GrantCommon Stock | 61,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088254 · ownership.xml · nonDerivative · entry 1 Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,963 F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 16:05 UTC |
Schultes Birgit CEVP, Chief Scientific Officer
|
SaleCommon Stock | 8,508 | $9.21 | $78,358.68 |
DisclosureSEC source: 0001193125-26-006292 · ownership.xml · nonDerivative · entry 1 Schultes Birgit C · CIK 0002051419 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,533 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. F2 · balance_after: Includes 925 and 932 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:01 UTC |
Dube Michael PVP, Chief Accounting Officer
|
SaleCommon Stock | 2,989 | $9.21 | $27,528.69 |
DisclosureSEC source: 0001193125-26-006264 · ownership.xml · nonDerivative · entry 1 Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,277 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 16:04 UTC |
Lebwohl DavidEVP, Chief Medical Officer
|
SaleCommon Stock | 11,903 | $9.21 | $109,626.63 |
DisclosureSEC source: 0001193125-26-006283 · ownership.xml · nonDerivative · entry 1 Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,249 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. F2 · balance_after: Includes 1,022 and 1,264 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:05 UTC |
BASTA JAMESEVP, General Counsel
|
SaleCommon Stock | 10,397 | $9.21 | $95,756.37 |
DisclosureSEC source: 0001193125-26-006291 · ownership.xml · nonDerivative · entry 1 BASTA JAMES · CIK 0001792726 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,528 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:05 UTC |
LEONARD JOHN MDirector · President and CEO
|
SaleCommon Stock | 34,146 | $9.21 | $314,484.66 |
DisclosureSEC source: 0001193125-26-006294 · ownership.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,013,339 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:03 UTC |
Clark ElianaEVP, Chief Technical Officer
|
SaleCommon Stock | 9,515 | $9.21 | $87,633.15 |
DisclosureSEC source: 0001193125-26-006278 · ownership.xml · nonDerivative · entry 1 Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,118 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. F2 · balance_after: Includes 1,264 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2025. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:05 UTC |
Cohen Fred EDirector
|
PurchaseCommon Stock | 150,000 | $9.35 | $1,402,500.00 |
DisclosureSEC source: 0001193125-26-006288 · ownership.xml · nonDerivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,453 F1 · kind: Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $9.68, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on January 5, 2026 at each separate price. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:02 UTC |
Dulac Edward J IIIEVP, Chief Financial Officer
|
SaleCommon Stock | 6,379 | $9.21 | $58,750.59 |
DisclosureSEC source: 0001193125-26-006275 · ownership.xml · nonDerivative · entry 1 Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,683 F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 21:09 UTC |
LEONARD JOHN MDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,557 | $0.00 Strike: $6.83 | $0.00 |
DisclosureSEC source: 0001193125-25-317551 · ownership.xml · derivative · entry 8 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,557 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested in full as of December 11, 2025. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 21:09 UTC |
LEONARD JOHN MDirector · President and CEO
|
Exercise / conversionCommon Stock | 8,557 | $6.83 | $58,444.31 |
DisclosureSEC source: 0001193125-25-317551 · ownership.xml · nonDerivative · entry 5 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,047,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:09 UTC |
LEONARD JOHN MDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 49,959 | $0.00 Strike: $6.83 | $0.00 |
DisclosureSEC source: 0001193125-25-317551 · ownership.xml · derivative · entry 7 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,557 Underlying: Common Stock · 49,959 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested in full as of December 11, 2025. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:09 UTC |
LEONARD JOHN MDirector · President and CEO
|
SaleCommon Stock | 5,355 | $9.59 | $51,354.45 |
DisclosureSEC source: 0001193125-25-317551 · ownership.xml · nonDerivative · entry 4 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,038,928 F1 · kind: The sales reported on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.57 to $9.65, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:09 UTC |
LEONARD JOHN MDirector · President and CEO
|
SaleCommon Stock | 32,832 | $9.47 | $310,919.04 |
DisclosureSEC source: 0001193125-25-317551 · ownership.xml · nonDerivative · entry 3 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,044,283 F1 · kind: The sales reported on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.57, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:09 UTC |
LEONARD JOHN MDirector · President and CEO
|
SaleCommon Stock | 49,959 | $9.49 | $474,110.91 |
DisclosureSEC source: 0001193125-25-317551 · ownership.xml · nonDerivative · entry 2 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,077,115 F1 · kind: The sales reported on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.33 to $9.64, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:09 UTC |
LEONARD JOHN MDirector · President and CEO
|
Exercise / conversionCommon Stock | 49,959 | $6.83 | $341,219.97 |
DisclosureSEC source: 0001193125-25-317551 · ownership.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,127,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.